Introduction
============

Measles vaccination made an important contribution to the millennium development goal to reduce under-5 mortality (MDG4),[@R1] accounting for 23% of the estimated worldwide decline in all-cause child mortality from 1990 to 2008.[@R2]^,^[@R3] A cornerstone of the strategy was that all children be offered a second opportunity to receive a dose of measles-containing vaccine, either through routine immunization services or through mass vaccination campaigns (known as supplementary immunization activities).[@R4] Supplemental immunization targets all children, to reach those who have been missed by routine services and also those who may have failed to develop an appropriate immune response after vaccination.[@R4] The strategy has been widely implemented in sub-Saharan Africa over the last decade, with measurable success in reducing mortality.[@R5] India delayed implementing supplementary immunization, and this may have contributed to the slower decline in measles mortality as compared with sub-Saharan Africa. India's share of global measles mortality increased from 16% of 535 300 deaths (95% confidence interval, CI: 347 200--976 400) in 2000 to 47% of 139 300 deaths (95% CI: 71 200--447 800) in 2010.[@R6]

In 2010, India introduced a second opportunity to receive measles-containing vaccine through routine immunization programmes in states with 80% or higher coverage of the first dose of measles-containing vaccine, and elsewhere through supplementary immunization activities. India's first supplementary mass measles vaccination campaign took place from 2010 to 2013 in 14 states[@R7] containing 59% of India's 113 million under-5 children (authors' calculations based on census data).[@R8] These 14 states have relatively weak health systems compared with the national average[@R9] and poorer progress towards MDG4.[@R10] The supplementary immunization activity reached 119 million children aged nine months to 10 years, achieving 91% coverage of the target population of 130 743 905.[@R11] India's first round of supplementary mass measles vaccination delivered only a measles-containing vaccine dose. Planning is underway for a larger measles--rubella vaccine introduction campaign targeting children aged 1--15 years.[@R12]

Campaign-style delivery has two key advantages over routine services; it can achieve high coverage even in areas where the reach of routine services is weak[@R2] and it reduces access barriers. On the other hand, a weakness of campaign delivery is that it represents a one-time or cyclic event. Some countries have made strategic use of mass vaccination campaigns to offer additional health interventions such as vitamin A supplements, insecticide-treated bednets and deworming medicines.[@R2] Therefore, vaccination campaigns could serve as an important platform to extend the reach of health services to underserved groups and improve maternal and child survival.

To date, India has largely not included add-on interventions with its mass vaccination campaigns and Indian health planners have expressed concerns over the potential challenges of implementing these, while agreeing that add-ons could be beneficial in principle.[@R9] To inform the design of future supplementary immunization activities in India and elsewhere we aimed to project the impact on mortality of a hypothetical set of technically feasible, high-impact interventions for maternal and child survival, delivered during India's 2010--2013 mass measles vaccination campaign.

Methods
=======

For states participating in the supplementary immunization activity, we conducted a mathematical modelling study to quantify: (i) the number of lives saved by a supplementary immunization activity delivering measles-containing vaccine alone, and (ii) the number of lives that could be saved by a supplementary immunization activity package delivering measles-containing vaccine plus a set of six hypothetical add-on interventions. The analysis baseline reflected existing coverage levels for all interventions offered through routine services. Within each state we also assessed the impact of the interventions on mortality by child's sex. Ethics approval was not required for this study as it used only secondary data with no personal identifiable information. A technical appendix containing full details of the methods is available from the corresponding author.

Selection of interventions
--------------------------

We selected add-on interventions for modelling through a literature review and expert consultation. First, we used two systematic reviews to identify maternal and child health interventions that had been linked to routine immunization or vaccination campaigns (but not specific to measles) in a low- or middle-income country, identified from two systematic reviews.[@R13]^,^[@R14] Then we updated the literature search from these reviews to 15 May 2015, and consulted supplementary sources.[@R2]^,^[@R15]^--^[@R17] Further suggestions were contributed by programme experts, including administrators and managers involved in India's 2010--2013 measles supplementary immunization activities.[@R2]^,^[@R9] From these inputs we prepared a comprehensive list of potential add-on interventions. Next, we condensed the list based on a review of the evidence of the feasibility of interventions, matched to target population and effectiveness, in the context of a supplementary immunization activity.[@R3] Finally, three experts engaged with India's immunization programme at central and state levels prioritized the interventions to create a shortlist of interventions for analysis based on criteria of programmatic and technical feasibility and policy relevance ([Table 1](#T1){ref-type="table"}). A total of six interventions -- generally offered in India through the routine health system -- were selected: (i) nutritional screening of children linked to services for complementary feeding; (ii) vitamin A supplementation for children; (iii) preventive zinc supplementation for children; (iv) free distribution of insecticide-treated bednets; (v) multiple micronutrient supplementation for pregnant women (iron, folic acid, vitamin A); and (vi) calcium supplementation for pregnant women.

###### Appraisal of potential add-on interventions for supplementary immunization activities in India

  Intervention                                                           Feasible in a single contact   Match to SIA target population   Effective (reduces mortality) in SIA context   Outcome of appraisal
  ---------------------------------------------------------------------- ------------------------------ -------------------------------- ---------------------------------------------- -------------------------
  **Child health intervention**                                                                                                                                                         
  Nutritional screening                                                  Yes                            Yes                              Likely                                         Selected^a^
  Vitamin A supplementation                                              Yes                            Yes                              Yes                                            Selected^a^
  Promotion of oral rehydration salts or therapy                         Yes                            Yes                              Uncertain                                      Recommended^b^
  Free distribution of oral rehydration salts                            Yes                            Yes                              Uncertain                                      Recommended^b^
  Deworming                                                              Yes                            Yes                              No                                             Recommended^b^
  Preventive zinc supplementation                                        Yes                            Yes                              Uncertain                                      Selected^a^
  Free distribution of insecticide-treated bednets                       Yes                            Yes                              Yes                                            Selected^a^
  Oral polio vaccine                                                     Yes                            Yes                              No                                             Recommended^b^
  DTP vaccine catch-up/booster dose                                      Yes                            Yes                              Likely                                         Challenging^c^
  Japanese encephalitis vaccine                                          Yes                            Yes                              Likely                                         Challenging^c^
  Pneumococcal vaccine                                                   Yes                            Yes                              Likely                                         Challenging^c^
  Rubella (measles--rubella) vaccine                                     Yes                            Yes                              Likely                                         Recommended^b^
  Cholera vaccine                                                        Yes                            Likely                           Yes                                            Challenging^c^
  **Pregnancy intervention^d^**                                                                                                                                                         
  Multiple micronutrient supplementation (iron, folic acid, vitamin A)   Yes                            To some extent                   Yes                                            Selected^a^
  Calcium supplementation                                                Yes                            To some extent                   Yes                                            Selected^a^
  Deworming                                                              Yes                            To some extent                   No                                             Recommended^b^
  Tetanus toxoid vaccine                                                 Yes                            To some extent                   Yes                                            Challenging^c^
  Promotion of breastfeeding                                             Yes                            To some extent                   Uncertain                                      Potentially valuable^e^
  **Additional intervention**                                                                                                                                                           
  Family planning                                                        No                             Yes                              Uncertain                                      Potentially valuable^e^
  Screening for unmet needs and health service referrals                 Yes                            Yes                              Likely                                         Recommended^b^

SIA: supplementary immunization activity; DTP: diphtheria--tetanus--pertussis.

^a^ Interventions selected for modelling in this analysis.

^b^ Interventions recommended as appropriate but lower priority for this analysis due to low impact on mortality or lack of evidence.

^c^ With the exception of combination vaccines, offering additional vaccines was viewed as challenging due to issues of logistics, safety and human resources.

^d^ Scope for pregnancy interventions depends on the proportion of children brought by mothers to receive measles vaccine and the proportion of pregnant women.

^e^ Interventions judged to be potentially valuable but lower priority for this analysis due to the need for empirical investigation.

Note: Further details of the appraisal are available from the corresponding author.

Decision modelling
------------------

We modelled the impact of the interventions on maternal and child mortality over the period 2009--2013 using the freely available Lives Saved Tool (LiST), version 4.7 (Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America). LiST is a mathematical model that synthesizes evidence on the causes of maternal and child mortality and the effectiveness of interventions to combat them.[@R18] The structure of the model has been described elsewhere.[@R19] LiST can be used to project the impact that multiple interventions may have on survival. LiST was chosen because its target populations are similar to those of India's measles supplementary immunization activities. In addition, validation studies comparing actual measured mortality with modelled mortality showed that LiST provided accurate predictions in diverse geographical settings, including northern India.[@R20]

State-level analyses
--------------------

### Model parameters

Of the 14 states targeted for supplementary immunization, two were excluded from our analysis, as data on health services coverage (Nagaland, population 1 978 502)[@R8] and population structure (Arunachal Pradesh, population 1 383 727)[@R8] required for model parameterization were unavailable. LiST developers have made available parameterized models representing India and the state of Bihar in 2008 and we created LiST models for 11 additional supplementary immunization activity states by tailoring the Indian LiST module.

We used recent demographic projections for India to create age- and sex-structured populations for modelling.[@R10] Estimates for the effectiveness of add-on interventions were taken from the child health epidemiology reference group (CHERG) systematic reviews incorporated in LiST, with the exception of vitamin A supplementation for which we used a more recent meta-analysis incorporating findings from the Deworming and Enhanced Vitamin A Trial (DEVTA) in Uttar Pradesh, India.[@R21] We developed state-specific proportional mortality estimates by mapping cause-of-death data from India's Million Deaths Study (MDS)[@R22]^,^[@R23] to the LiST model categories. The MDS is a nationally representative longitudinal study of premature mortality monitoring 14 million people in India, which assigns cause of death by physician-reviewed verbal autopsy. For Manipur, Meghalaya and Tripura, state-specific mortality data were not available and for these states we used regional proportional mortality estimates. The MDS did not evaluate pertussis deaths as a separate category due to the difficulty of distinguishing pertussis from causes of death such as pneumonia when using verbal autopsy techniques. We imputed pertussis deaths using CHERG methods.[@R24]^,^[@R25] To characterize immunization coverage before the supplementary immunization activity, values for other parameters were derived from Indian household surveys. The principal data source was India's 2007--2008 district level household and facility survey;[@R26] data were collected just before the measles supplementary immunization. The technical appendix with illustrations of parameter values and data sources for a sample state are available from the corresponding author. Coverage data for the 2010--2013 measles supplementary immunization were provided by the Government of India.

### Integrated vaccination campaign package

We modelled the supplementary immunization activity as occurring in all states in a single year (2010). The campaign would confer a one-time increase in measles vaccination coverage. Some of the hypothetical interventions, such as delivering vitamin A supplements and carrying out nutritional screening, could be completed at the time of vaccination. For these interventions, increases in coverage were modelled as a function of measles-containing vaccine coverage achieved by the supplementary immunization. Vitamin A supplements for children should be given twice per year; a single dose of vitamin A represents half the annual recommended dose. We therefore calculated the increase in vitamin A coverage conferred by the supplementary immunization as: achieved coverage divided by 2. Nutritional screening is effective only when linked to programmes and services. Based on expert opinion, we assumed that 90% of children screened and found nutritionally deficient would be linked to follow-up services, including complementary feeding, through programmes such as India's integrated child development services. Several other interventions would require additional follow-through to be effective. For three interventions (multiple micronutrient and calcium supplements for pregnant women and preventive zinc for children) we modelled the causal chain between being offered in the supplementary immunization activity and increased intervention coverage as depending on measles-containing vaccine achievement and compliance. For these interventions, we used an average compliance scenario of 70% and considered two additional scenarios bounding reasonable ranges of low (50%) and high (90%) compliance. We assumed that 73% of freely distributed long-lasting insecticide-treated bednets would be used.[@R27] The analytic assumptions are outlined in [Table 2](#T2){ref-type="table"} (available at: <http://www.who.int/bulletin/volumes/94/10/15-160044>), with further details available from the corresponding author.

###### Assumptions used in the analysis of measles vaccine with a package of six add-on interventions for the supplementary immunization activity in India

  Assumption                                                                                                                                                 Value                                   Source
  ---------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- -------------------------------
  **Efficacy of measles vaccine in reducing measles mortality**                                                                                              0.85                                    Published study[@R18]
  **Duration of benefit conferred by SIA interventions**                                                                                                                                             
  Insecticide-treated bednets                                                                                                                                3 years                                 Published study[@R28]
  Measles vaccine                                                                                                                                            Lifelong (beyond analysis timeframe)    Published study[@R29]
  All other interventions^a^                                                                                                                                 \< 1 year                               Published study[@R18]
  **Proportion of individuals likely to use SIA add-on interventions**                                                                                                                               
  Insecticide-treated bednets                                                                                                                                73%                                     Published study[@R27]
  Multiple micronutrient supplements for pregnant women                                                                                                      70% compliance (50% low; 90% high)^b^   Expert opinion and field data
  Calcium supplements for pregnant women                                                                                                                     70% compliance (50% low; 90% high)^b^   Expert opinion and field data
  Preventive zinc for children                                                                                                                               70% compliance (50% low; 90% high)^b^   Expert opinion
  **Proportion of children identified in the SIA as having nutritional deficiencies and linked to services for complementary feeding and supplementation**   90%^c^                                  Expert opinion
  **Proportion of pregnant women reached by the SIA**                                                                                                        Varies by state, range 21% to 52%       Calculated
  **Increase in vitamin A coverage achieved through the SIA**                                                                                                SIA coverage divided by 2^d^            Calculated
  **SIA reaches male and female children equally**                                                                                                           --                                      Published study[@R30]
  **SIA does not reduce coverage of routine services**                                                                                                       --                                      Assumed

SIA: supplementary immunization activity.

^a^ This category comprises nutritional screening; vitamin A supplementation for children; preventive zinc supplementation for children; multiple micronutrient supplementation in pregnant women (iron, folic acid, vitamin A); and calcium supplementation in pregnant women.

^b^ Further details of compliance scenarios are available from the corresponding author.

^c^ This estimate for linkage to services is based on the mandate and capacity of India's integrated child development services programme.

^d^ As Vitamin A supplements should be given twice per year, this represents half an annual dose.

### Sensitivity analyses

Additional analyses explored the effect of using different sources of data for proportional mortality (i.e. comparing proportional mortality data for India from CHERG and state-specific proportional mortality data from the MDS). We also quantified the impact of parameter uncertainty related to the effectiveness of vitamin A supplementation on diarrhoea mortality for children aged 6--59 months. To do this we contrasted the DEVTA meta-analysis midpoint estimate of 11%[@R21] with the 47% mortality benefit incorporated in LiST.[@R18] Finally, we developed the Dynamic Measles Immunization Calculation Engine, a transmission dynamic measles model[@R31] that enabled us to consider factors not captured in LiST, such as age-specific vaccine efficacy for measles first and second doses, and herd immunity, to model the impact on mortality of the supplementary immunization activity delivering only measles-containing vaccine.

### Equity impact

Equity analyses were done on a state-by-state basis and assumed that increases in supplementary immunization coverage reached both sexes equally. To quantify the impact of the mass vaccination campaign on sex differences in child mortality, we used sex-specific proportional mortality data from the MDS[@R22] and sex-specific coverage data from the third round of the district level household and facility survey[@R26] and other sources (further details are available from the corresponding author). We assessed the impact on gender equity of the campaign delivering measles vaccine only and the hypothetical campaign delivering measles vaccine and add-on interventions by comparing the proportion of hypothetical lives saved by the campaign for girls versus boys, and the under-5 mortality rate per 1000 live births for girls versus boys in the years before (2009) and after (2010) the measles campaign.

Results
=======

Overall results
---------------

India's decision to introduce a second opportunity for measles vaccination via mass vaccination campaign saved the lives of an estimated 19 016 under-5 children in the 12 states included in our analysis, of whom 11 121 (58%) were in the state of Uttar Pradesh ([Table 3](#T3){ref-type="table"}).

###### Estimated number of under-5 lives saved in 12 states participating in India's 2010--2013 measles supplementary immunization activity

  State            No. (%)          
  ---------------- ---------------- -----------------------
  Assam            378 (2.0)        3 556 222 (4.8)
  Bihar            3 436 (18.1)     13 811 150 (19.2)
  Chhattisgarh     79 (0.4)         3 014 655 (3.8)
  Gujarat          262 (1.4)        6 293 984 (8.2)
  Haryana          435 (2.3)        2 763 215 (3.6)
  Jharkhand        353 (1.9)        4 022 926 (5.5)
  Madhya Pradesh   1 864 (9.8)      8 899 016 (11.2)
  Manipur          32 (0.2)         257 601 (0.4)
  Meghalaya        33 (0.2)         416 638 (0.6)
  Rajasthan        996 (5.2)        8 852 191 (11.0)
  Tripura          27 (0.1)         339 014 (0.5)
  Uttar Pradesh    11 121 (58.5)    24 945 895 (30.7)
  All states^b^    19 016 (100.0)   77 172 507 (100.0)^c^

SIA: supplementary immunization activity.

^a^ Author's calculations based on Government of India census statistics.[@R8]

^b^ Including all participating states in the 2010--2013 measles SIA.

^c^ SIA states contained 59% of the under-5 population of India.[@R8]

Note: Analyses use proportional mortality from the Million Deaths Study[@R22] and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.[@R21] Lives saved were calculated for the period 2010--2013.

[Table 4](#T4){ref-type="table"} shows the projected lives saved in these states by a hypothetical supplementary immunization package that included measles vaccine and high-impact add-on interventions for children and pregnant women. This was based on a scenario of 70% compliance with interventions (when applicable) and on mortality data from India's MDS. Maternal lives saved were due to calcium supplementation in pregnancy; all other lives saved represented under-5 children. Summing over all states, including maternal and child health interventions in the measles supplementary immunization campaign would have saved around 73 900 (range: 70 200--79 300), preventing 73 700 child deaths (range: 70 000--79 900) and 300 maternal deaths (range: 200--400). The hypothetical campaign offering measles vaccine with add-on interventions was therefore projected to increase the number of lives saved by a factor of 3.89 (range: 3.69 to 4.17) compared with offering measles vaccine alone. The benefits of the add-ons were also distributed among states more closely to the proportion of the population ([Table 3](#T3){ref-type="table"} and [Table 4](#T4){ref-type="table"}; supplementary data are available from the corresponding author). For example, Uttar Pradesh, which had 30.7% of the under-5 target population for the supplementary immunization, gained 58.5% of lives saved from the measles-only supplementary immunization ([Table 3](#T3){ref-type="table"}) and 36.0% of lives saved from the package of measles supplementary immunization with add-ons ([Table 4](#T4){ref-type="table"}).

###### Projected number of lives saved due to a hypothetical package of measles vaccine with a set of additional maternal and child health interventions during the measles supplementary immunization activity, India 2010--2013

  Compliance scenario and state            No. of lives saved                                                                   
  ------------------------------- -------- -------------------- -------- ------- ------- ------- ----- -- ------- ------- ----- --------
  **By state (70% scenario)**                                                                                                   
  Assam                           365      3 611                810      254     149     131     16       121     93      31    5 581
  Bihar                           3 265    3 981                3 030    1 076   595     415     43       417     421     169   13 412
  Chhattisgarh                    76       1 691                301      123     126     41      10       33      56      8     2 465
  Gujarat                         256      733                  677      156     250     107     11       63      75      53    2 381
  Haryana                         421      374                  246      61      122     50      5        23      19      15    1 336
  Jharkhand                       338      2 945                773      192     172     101     13       92      100     24    4 750
  Madhya Pradesh                  1 791    4 240                2 163    532     499     264     28       234     301     97    10 149
  Manipur                         31       177                  62       42      12      8       1        46      53      35    467
  Meghalaya                       32       180                  82       9       14      10      1        48      56      35    467
  Rajasthan                       962      2 256                1 604    268     479     175     34       95      204     41    6 118
  Tripura                         27       206                  69       9       10      10      1        4       6       1     343
  Uttar Pradesh                   10 671   4 539                5 712    1 562   1 333   781     108      662     643     449   26 460
  **All states**                                                                                                                
  70% scenario                    18 235   24 933               15 529   4 284   3 761   2 093   271      1 838   2 027   958   73 929
  50% scenario                    18 314   24 929               13 346   4 292   2 687   2 109   196      1 647   1 806   829   70 155
  90% scenario                    18 159   24 934               19 849   4 235   4 838   2 080   350      1 870   2 061   945   79 321

^a^ Lives saved due to the intervention listed in the column header.

^b^ These are maternal deaths; all other deaths represent children younger than 5 years.

^c^ Additional lives saved due to prevention of disease (not intervention-specific).

Note: Including 12 states participating in India's 2010--2013 measles supplementary immunization activity. Analyses use proportional mortality from the Million Deaths Study[@R22] and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.[@R21] Lives saved were calculated for the period 2010--2013. Compliance figures apply to multiple micronutrients and calcium for pregnant women, and preventive zinc for children; compliance scenarios are outlined in [Table 2](#T2){ref-type="table"}.

We explored which add-on interventions in the whole package contributed most to the anticipated reductions in mortality ([Table 4](#T4){ref-type="table"}). Summing over all states for the average (70%) compliance scenario, the effectiveness of the interventions in descending order were: insecticide-treated bednets (24 933 lives saved), measles vaccine (18 235), preventive zinc supplementation (15 529), complementary feeding (4284), vitamin A supplementation (2093), multiple micronutrients supplementation during pregnancy (3761) and calcium supplementation during pregnancy (271). Some of the lives saved by the supplementary immunization with add-ons could not be attributed to specific interventions and are presented instead by syndrome, including diarrhoea (1838 lives saved), pneumonia (2027) and measles (958). Applying the low (50%) compliance scenario over all states resulted in the same ranking of interventions, while for the high (90%) compliance scenario, the interventions in descending order of importance were: bednets, zinc, measles vaccine, multiple micronutrients, complementary feeding, vitamin A and calcium.

The contribution to mortality reduction of specific interventions varied considerably among states, reflecting differences in local epidemiology and coverage of health services before the measles vaccination campaign. For the average compliance scenario, measles vaccine conferred 3% of the anticipated benefit in Chhattisgarh (i.e. 76/2465 lives saved) and 40% in Uttar Pradesh (10 671/26 460); insecticide-treated bednets conferred 17% of the benefit in Uttar Pradesh (4539/26 460) and 69% in Chhattisgarh (1691/2465); while zinc conferred 12% of the benefit in Chhattisgarh (301/2465) and 28% (677/2381) in Gujarat ([Table 4](#T4){ref-type="table"}).

Sensitivity analyses
--------------------

Using different assumptions about proportional mortality affected the findings shown in [Table 4](#T4){ref-type="table"}. Proportional mortality based on the MDS data attributed greater importance to malaria deaths and hence a higher projected number of lives saved by insecticide-treated bednets (24 933/73 929 lives saved across all states) than did proportional mortality based on the CHERG data (4591/69 912 lives saved). Uncertainty concerning the effectiveness of vitamin A supplementation in reducing diarrhoea deaths among children aged 6--59 months had an important impact; higher CHERG values appreciably increased the projected lives saved due to administration of vitamin A (6637/77 979) compared with the DEVTA trial values (2093/73 929). A dynamic model replicating India's 2010--2013 measles supplementary immunization activity projected that a one-time supplementary immunization delivering only measles-containing vaccine would have saved 47 625 to 95 249 lives of under-5 children, assuming a case-fatality ratio of 1--2%.[@R6]^,^[@R32]

Equity analyses
---------------

The campaign mitigated pre-existing inequalities in mortality between girls and boys. For under-5 children, the supplementary immunization delivering only measles-containing vaccine were projected to save the lives of 12 712 (66%) girls and 6 635 (34%) boys. The hypothetical campaign delivering measles vaccine and add-on interventions, based on the 70% compliance scenario, saved an expected 45 721 (62%) girls and 28 647 (39%) boys ([Table 5](#T5){ref-type="table"}; additional supplementary data are available from the corresponding author). For the eight states in which under-5 mortality per 1000 live births was initially greater in girls than in boys, the gender disparity was reduced by the supplementary immunization activity offering measles-containing vaccine only and further reduced by the hypothetical campaign delivering measles vaccine and add-on interventions ([Table 6](#T6){ref-type="table"}).

###### Projected number of lives saved for under-5 children due to measles vaccine only or due to a hypothetical package of measles vaccine with a set of additional maternal and child health interventions during the measles supplementary immunization activity, India 2010--2013, by child's sex

  State            Lives saved by measles vaccine only                     Lives saved by measles vaccine with add-on interventions^a^                                     
  ---------------- ------------------------------------- ----------------- ------------------------------------------------------------- -- ------------ ----------------- -----------------
  Assam            379                                   242 (64)          138 (36)                                                         5 579        3 090 (55)        2489 (45)
  Bihar            3 439                                 2 231 (65)        1 209 (35)                                                       13 373       8 456 (63)        4 917 (37)
  Chhattisgarh     77                                    34 (45)           42 (55)                                                          2 438        1 169 (48)        1 270 (52)
  Gujarat          299                                   200 (67)          99 (33)                                                          2 396        1 397 (58)        999 (42)
  Haryana          430                                   269 (62)          161 (38)                                                         1 334        850 (64)          484 (36)
  Jharkhand        355                                   225 (63)          130 (37)                                                         4 695        2 493 (53)        2 202 (47)
  Madhya Pradesh   1 899                                 999 (53)          900 (47)                                                         10 379       5 730 (55)        4 649 (45)
  Manipur          32                                    14 (45)           18 (55)                                                          329          158 (48)          171 (52)
  Meghalaya        33                                    15 (46)           18 (54)                                                          337          164 (49)          173 (51)
  Rajasthan        1 080                                 831 (77)          249 (23)                                                         6 292        4 268 (68)        2 024 (32)
  Tripura          27                                    13 (49)           14 (51)                                                          376          199 (53)          176 (47)
  Uttar Pradesh    11 296                                7 639 (68)        3 657 (32)                                                       26 839       17 747 (66)       9 093 (34)
  **Total^b^**     **19 346**                            **12 712 (66)**   **6 635 (34)**                                                   **74 367**   **45 721 (61)**   **28 647 (39)**

^a^ Add-on interventions were nutritional screening linked to complementary feeding; vitamin A supplementation for children; preventive zinc supplementation for children; free distribution of insecticide-treated bednets; multiple micronutrient supplementation in pregnant women (iron, folic acid, vitamin A); and calcium supplementation in pregnant women.

^b^ State totals represent the sum of sex-specific models and thus differ from [Table 3](#T3){ref-type="table"}.

Note: Including 12 states participating in India's 2010--2013 measles supplementary immunization activity. Analyses use proportional mortality from the Million Deaths study[@R22] and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.[@R21] Lives saved were calculated for the period 2010--2013. Data are based on the 70% compliance scenario (see [Table 2](#T2){ref-type="table"}) and apply to multiple micronutrients and calcium during pregnancy, and preventive zinc for children.

###### Projected under-5 mortality in the years before (2009) and after (2010) the measles supplementary immunization activity, India 2010--2013, by child's sex

  State                          Measles vaccine only                 Measles vaccine with add-on interventions^a^                                                          
  ---------------- ------ ------ ---------------------- ------ ------ ---------------------------------------------- ------ ------ ------ ------ -- ------ ------ -- ------ ------
  Assam            87.0   86.4                          79.0   78.7                                                  −0.6   −0.3   87.9   83.4      79.9   76.3      −4.5   −3.6
  Bihar            68.0   66.3                          60.0   59.0                                                  −1.7   −1.0   68.3   63.3      60.3   57.4      −5.0   −2.9
  Chhattisgarh     61.0   60.9                          61.0   60.9                                                  −0.1   −0.1   62.2   59.8      62.2   59.9      −2.4   −2.3
  Gujarat          60.0   59.7                          52.0   51.9                                                  −0.3   −0.1   60.5   58.9      52.5   51.4      −1.6   −1.1
  Haryana          59.0   58.0                          50.5   51.0                                                  −1.0   0.5    60.2   57.5      52.2   50.7      −2.7   −1.5
  Jharkhand        59.0   58.2                          59.0   58.7                                                  −0.8   −0.3   59.9   56.1      59.9   56.7      −3.8   −3.2
  Madhya Pradesh   85.0   83.9                          82.0   81.0                                                  −1.1   −1.0   85.4   81.0      82.4   78.9      −4.4   −3.5
  Manipur          79.0   78.5                          79.0   78.3                                                  −0.5   −0.7   89.5   87.7      89.5   87.5      −1.8   −2.0
  Meghalaya        79.0   78.6                          79.0   78.5                                                  −0.4   −0.5   89.8   88.0      89.8   87.8      −1.9   −2.0
  Rajasthan        79.0   78.0                          60.0   59.7                                                  −1.0   −0.3   79.5   75.7      60.5   58.7      −3.8   −1.8
  Tripura          79.0   78.6                          79.0   78.6                                                  −0.4   −0.4   87.2   84.6      87.2   85.0      −2.6   −2.2
  Uttar Pradesh    87.0   83.8                          71.0   69.5                                                  −3.2   −1.5   87.2   81.1      71.2   68.1      −6.1   −3.1

^a^ Add-on interventions were nutritional screening linked to complementary feeding; vitamin A supplementation for children; preventive zinc supplementation for children; free distribution of insecticide-treated bednets; multiple micronutrient supplementation in pregnant women (iron, folic acid, vitamin A); and calcium supplementation in pregnant women.

^b^ Results were calculated without applying background trends in acquired immune deficiency syndrome mortality.

Note: Including 12 states participating in India's 2010--2013 measles supplementary immunization activity. Analyses use proportional mortality from the Million Deaths Study[@R22] and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.[@R21] Lives saved were calculated for the period 2010--2013.

Discussion
==========

Measles vaccination is important for reduction of child mortality, yet global coverage of the first dose of measles-containing vaccine has been stagnant since 2009.[@R1] Mass vaccination campaigns are resource-intensive and planners must assess their value among a range of options for health improvement and resource expenditure. Our analysis demonstrated that India's introduction of a second opportunity for measles vaccination through large-scale campaigns from 2010 to 2013 made an important contribution to reducing mortality from measles. Our model-based analysis of 12 of the 14 participating states found that India's measles supplementary immunization activity likely saved the lives of approximately 19 000 under-5 children, corresponding to roughly 29% (range: 24% to 35%) of India's annual measles mortality.[@R6] We also found that a hypothetical supplementary immunization package delivering measles vaccine and a set of additional interventions of known effectiveness would increase the impact on mortality of the mass measles vaccination campaign more than threefold. Despite variation among states, the most important interventions in the package overall were insecticide-treated bednets, measles vaccine and preventive zinc supplementation. This reflects the high burden of infectious disease and undernutrition among Indian children, the impact of malaria in some areas and the relatively low coverage of these key interventions.[@R24]^--^[@R26]

Child mortality in India differs markedly by sex, with higher mortality rates recorded for girls.[@R10]^,^[@R22] Caregiver bias associated with preference for a male child likely contributes to the mortality differentials due to lower use of regular health services for girls. Vaccination campaigns, however, show a more equal pattern of use.[@R30] We found that, due to the high coverage achieved in states with weak health systems, supplementary immunization helped to mitigate gender-related inequities in child mortality. We also studied differences in mortality for subgroups defined by household wealth status (quintiles) and area of residence (rural/urban). However, the results were uninformative due to the absence of state- and stratum-specific proportional mortality data (available from the corresponding author).

The components of this integrated health package for a supplemental mass vaccination campaign were designed based on a systematic appraisal of the evidence and a quantitative projection of likely impact. Add-on interventions were systematically selected using the published scientific literature and expert guidance.[@R9] A key advantage of this approach is that it presents the evidence and assumptions in a transparent framework that permits alternatives to be explored. We placed particular emphasis on defining options for analysis that were evidence-based, feasible and relevant to the Indian context. Cause-of-death data from India's MDS[@R22] enabled us to show state- and sex-specific mortality patterns, while data from recent household surveys[@R26] facilitated an accurate portrayal of health services coverage. LiST is a validated policy model that enables competing mortality risks to be considered.[@R19] In addition, we validated the LiST projections of the impact of measles-containing vaccine using a transmission dynamic model that takes into account both herd immunity and age-specific vaccine efficacy. As anticipated, the dynamic model results were consistent with LiST results but showed a somewhat higher impact on mortality for the supplementary immunization with measles vaccine.

We highlight five limitations of the analysis. First, the LiST model focuses only on mortality. Many of the add-on interventions studied also reduce morbidity, and some potentially important interventions, such as antihelminthic drugs, were not considered as their direct impact is exclusively on morbidity.[@R2] Second, limited availability of data forced us to exclude two states of less than 2 million inhabitants each.[@R3]^,^[@R8] Third, uncertainty concerning parameter values for vitamin A effectiveness, proportional mortality due to malaria, and compliance were found to influence mortality projections.[@R4] Fourth, our mortality projections represent a specific point in time, whereas child survival and health services coverage are changing rapidly in India.[@R5] Finally, due to constraints of logistics, it may not be possible in practice to offer as many add-on interventions as we have modelled for this analysis. Our primary purpose was to demonstrate the potential benefits of bundling proven interventions with a vaccination campaign. We also showed the utility of an evidence-based approach for planning add-ons for supplementary immunization activities. The integrated package studied in this analysis should be seen as aspirational. In practice, the impact on mortality will depend on the actual interventions offered and may be less than illustrated here.

Mass measles vaccination campaigns in many countries have offered additional interventions,[@R2] but the choice of which interventions to include has generally been made in an ad hoc way rather than through a systematic analysis such as the one illustrated here. Although the interventions we examined were all deemed by Indian health planners to be technically feasible to incorporate into mass vaccination campaigns, implementation research is needed to assess the feasibility and impact on health systems of offering these interventions. We also need to assess the cost--effectiveness of supplementary immunization activities that include measles vaccine and add-on maternal and child health interventions in India. As vaccination campaigns must be repeated periodically, this research has the potential to revitalize political support for accelerated measles control strategies, as well as for other vaccines delivered through mass campaigns, such as rubella and polio.
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